| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |